Michael Goggins
Johns Hopkins University · Sol Goldman Pancreatic Cancer Research Center, JHMI
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael Goggins as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:38 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT02000089 · The Cancer of the Pancreas Screening-5 CAPS5)StudyJohns Hopkins University · recruiting · Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation · principal investigator
- Ph1NCT01296763 · Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Pancreatic Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Personalizing biomarkers to improve pancreas surveillanceR01CA313242 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2026 · $642,504 awarded in 2026Same name and institution; not confirmed by an ID
- Using markers to improve pancreatic cancer screening and surveillance: a multi-center studyU01CA210170 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2016 to 2026 · $706,935 awarded in 2026Grant number is on one of their registry trials
- Using Markers to Improve Pancreatic Cancer ScreeningR01CA176828 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2013 to 2024 · $396,154 awarded in 2024Grant number is on one of their registry trials
- Markers for Screening and PrognosisP50CA062924 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2007 to 2016 · $285,911 awarded in 2016Same name and institution; not confirmed by an ID
- Markers of Early Pancreatic CancerR01CA120432 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2006 to 2010 · $282,659 awarded in 2010Same name and institution; not confirmed by an ID
- Predicting pancreatic cancer responses for a Parp inhibitor-based clinical trialRC2CA148346 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2009 to 2010 · $962,168 awarded in 2010Grant number is on one of their registry trials
- CLASSIFYING PANCREATIC CANCERS BY METHYLATOR PHENOTYPESR01CA090709 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2003 to 2006 · $265,431 awarded in 2006Same name and institution; not confirmed by an ID
- FOLATE PATHWAY POLYMORPHISMS AND PANCREATIC CANCER RISKR03CA092778 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2001 to 2002 · $81,750 awarded in 2002Same name and institution; not confirmed by an ID
- THE PanINs OF PANCREATITIS,PANCREAS CANCER AND CONTROLSR03CA091968 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2001 to 2002 · $81,750 awarded in 2002Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:38 UTC. The ranking covers the 200 most relevant of 12 PubMed records, and a shared surname and initials can bring in a namesake. All 12 on PubMed
- Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements.Am J Clin Nutr · 1997289 citationsRCR 9.3
- DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.Cancer Res · 2006172 citationsRCR 3.8
- Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer.Clin Gastroenterol Hepatol · 202287 citationsRCR 6.0
- Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer.Proc Natl Acad Sci U S A · 201875 citationsRCR 2.6
- Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study.Ann Surg Oncol · 201445 citationsRCR 2.0
- Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study.Gastrointest Endosc · 201539 citationsRCR 1.4
- Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study.Cancer Prev Res (Phila) · 202121 citationsRCR 1.1
- 17 citationsRCR 2.0
- Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.Transplant Proc · 199913 citationsRCR 0.7
- Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients.Transplant Proc · 19978 citationsRCR 0.4